| 1. | | Completed | Augmerosen Plus Fludarabine and Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
Conditions: recurrent adult acute myeloid leukemia; recurrent adult acute lymphoblastic leukemia |
| 2. | | No longer recruiting | Bevacizumab and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer
Conditions: recurrent breast cancer; stage IV breast cancer |
| 3. | | Recruiting | Bevacizumab With or Without Interferon alfa in Treating Patients With Metastatic Malignant Melanoma
Conditions: Stage IV Melanoma; Recurrent Melanoma |
| 4. | | Recruiting | Bortezomib and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
| 5. | | Recruiting | CCI-779 in Treating Patients With Relapsed or Refractory Multiple Myeloma
Conditions: stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm |
| 6. | | Recruiting | Celecoxib in Treating Patients With Progressive Metastatic Differentiated Thyroid Cancer
Conditions: insular thyroid cancer; recurrent thyroid cancer; stage II follicular thyroid cancer; stage II papillary thyroid cancer; ... |
| 7. | | No longer recruiting | Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer
Condition: stage IIIA non-small cell lung cancer |
| 8. | | Completed | Chloroquinoxaline Sulfonamide in Treating Patients With Stage IV Colorectal Cancer
Conditions: recurrent colon cancer; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer |
| 9. | | No longer recruiting | Combination Chemotherapy in Treating Patients With Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
| 10. | | Recruiting | Decitabine and Valproic Acid in Treating Patients With Non-Small Cell Lung Cancer
Conditions: recurrent non-small cell lung cancer; stage IV non-small cell lung cancer |
| 11. | | Recruiting | Decitabine and Valproic Acid in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Conditions: adult acute myeloid leukemia; refractory chronic lymphocytic leukemia; Small Lymphocytic Lymphoma |
| 12. | | Recruiting | Erlotinib Plus Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Head and Neck Cancer
Condition: Head and Neck Cancer |
| 13. | | Suspended | Flavopiridol in Treating Patients With Previously Treated Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma
Conditions: B-cell Chronic Lymphocytic Leukemia; refractory chronic lymphocytic leukemia; Waldenstrom's Macroglobulinemia; recurrent small lymphocytic lymphoma |
| 14. | | Recruiting | Flavopiridol, Fludarabine, and Rituximab in Treating Patients With Lymphoproliferative Disorders or Mantle Cell Lymphoma
Conditions: adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; Hairy Cell Leukemia |
| 15. | | No longer recruiting | FR901228 in Treating Patients With Hematologic Cancer
Conditions: Waldenstrom's Macroglobulinemia; recurrent adult acute myeloid leukemia; recurrent adult acute lymphoblastic leukemia; ... |
| 16. | | Recruiting | FR901228 in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors
Conditions: gastrointestinal carcinoid tumor; Islet Cell Carcinoma; pulmonary carcinoid tumor |
| 17. | | Not yet recruiting | FR901228 in Treating Patients With Recurrent or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Acute Myeloid Leukemia
Conditions: adult acute myeloid leukemia; refractory chronic lymphocytic leukemia; Small Lymphocytic Lymphoma |
| 18. | | Recruiting | GTI-2040 and High-Dose Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia
Conditions: recurrent adult acute myeloid leukemia; adult acute myeloid leukemia with t(8;21)(q22;q22); adult acute myeloid leukemia with t(16;16)(p13;q22); ... |
| 19. | | No longer recruiting | Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of the HER2/neu Protein
Condition: Cancer |
| 20. | | No longer recruiting | Interleukin-12 Followed by Interferon alfa in Treating Patients With Advanced Cancer
Condition: Cancer |
| 21. | | Recruiting | Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors
Conditions: recurrent breast cancer; recurrent gastric cancer; recurrent non-small cell lung cancer; recurrent ovarian epithelial cancer; ... |
| 22. | | No longer recruiting | Monoclonal Antibody Therapy in Treating Patients With Chronic Lymphocytic Leukemia, Lymphocytic Lymphoma, Acute Lymphoblastic Leukemia, or Acute Myeloid Leukemia
Conditions: recurrent adult acute lymphoblastic leukemia; refractory chronic lymphocytic leukemia; stage III diffuse small lymphocytic/marginal zone lymphoma; ... |
| 23. | | Recruiting | Oblimersen, Cytarabine, and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia
Conditions: untreated adult acute myeloid leukemia; secondary acute myeloid leukemia; adult acute myeloid leukemia with t(8;21)(q22;q22); ... |
| 24. | | No longer recruiting | Oxaliplatin and Paclitaxel in Treating Patients With Metastatic or Unresectable Cancer
Condition: unspecified adult solid tumor, protocol specific |
| 25. | | Completed | Oxaliplatin in Treating Patients With Advanced Head and Neck Cancer
Conditions: lip and oral cavity cancer; Head and Neck Cancer; Oropharyngeal Cancer |
| 26. | | Completed | PS-341 in Treating Patients With Metastatic Neuroendocrine Tumors
Conditions: miscellaneous islet cell cancer; Gastrinoma; Insulinoma; Somatostatinoma; Glucagonoma; metastatic gastrointestinal carcinoid tumor |
| 27. | | Completed | Pyrazoloacridine in Treating Women With Refractory Metastatic Breast Cancer
Condition: recurrent breast cancer |
| 28. | | No longer recruiting | Radiation Therapy and Gadolinium Texaphyrin in Treating Patients With Supratentorial Glioblastoma Multiforme
Condition: adult glioblastoma multiforme |
| 29. | | No longer recruiting | Rituximab Plus Interleukin-2 in Treating Patients With Hematologic Cancer
Conditions: adult acute lymphoblastic leukemia; adult non-Hodgkin's lymphoma |
| 30. | | Not yet recruiting | Sorafenib in Treating Patients With Locally Advanced, Metastatic, or Locally Recurrent Thyroid Cancer
Conditions: anaplastic thyroid cancer; follicular thyroid cancer; insular thyroid cancer; papillary thyroid cancer; Thyroid Cancer |
| 31. | | Completed | SU5416, Irinotecan, and Cisplatin in Treating Patients with Advanced Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
| 32. | | Recruiting | Suramin and Either Docetaxel or Gemcitabine in Treating Patients With Stage IIIB or Stage IV Platinum-Refractory Non-Small Cell Lung Cancer
Conditions: recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer |
| 33. | | Recruiting | Suramin and Paclitaxel in Treating Women With Stage IIIB or Stage IV Breast Cancer
Conditions: recurrent breast cancer; stage IIIB breast cancer; stage IV breast cancer |
| 34. | | Completed | Suramin, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
Conditions: recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer |
| 35. | | No longer recruiting | Trastuzumab Plus Interleukin-2 in Treating Patients With Metastatic Breast Cancer
Conditions: stage IV breast cancer; recurrent breast cancer; Male Breast Cancer |
